Suicidality and Suicide Attempt Among HIV Patients on Efavirenz-containing Versus Efavirenz-free Antiretroviral Regimens

Bristol-Myers Squibb (BMS)

Status: Completed

Conditions: HIV Infection

Study type: Observational

Funder types: Industry; Other

Identifiers

NCT02211807

AI266-960

Details and patient eligibility

About

The purpose of this study was to compare the frequency of suicidality and suicide attempt among HIV patients starting treatment with Efavirenz and with patients starting treatment with other HIV medications.

Enrollment: 11,400 patients

Sex: All

Ages: 12+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com

Inclusion Criteria:

• At least 6 months of enrollment before first prescription
• Antiretroviral naive

Exclusion Criteria:

• No diagnosis of HIV on patient record
• Age < 12 years

Trial design

11,400 participants in 2 patient groups

Patients initiating an Efavirenz

Description:

Patients initiating an Efavirenz-containing antiretroviral regimen

Patients initiating an Efavirenz-free regimen